The MRC’s Infections and Immunity Board funds research into infectious human disease and disorders of the human immune system. The board supports a diverse portfolio of research of relevance to the UK and globally, and to address both long-standing questions and support the investigation of emerging higher-risk opportunities.
Research we fund includes, but is not limited to, the following areas:
- discovery research relating to human pathogens, pathogenicity, antimicrobial resistance, host pathogen responses including inflammation and the development function and disorders of the immune system where this informs mechanism of disease. Immune disease including allergy (except asthma and other organ-based disorders), transplantation immunology, systemic immune disorders and auto-immune disease. Including use of in silico systems, relevant animal models and experimental studies in humans throughout the lifecourse
- population-level research, using epidemiological, genetic and ‘omic approaches, and computational modelling, to elucidate disease risks, aetiologies and progression, and to understand the evolution of pathogen populations and epidemic preparedness
- research to inform novel strategies for preventing and controlling infectious and immune disease, including vector control, predictive modelling and early development research to inform future intervention strategies including vaccines.
Find out more about the science areas we support and our current board opportunity areas.
We encourage you to contact us first to discuss your application if you believe your research may cross MRC research board or research council interests. If your application fits another research board remit better we may decide to transfer it there to be assessed.
Medical Research Council infections and immunity research grants:
- are suitable for focused short or long-term research projects
- can support method development or development and continuation of research facilities
- may involve more than one research group or institution.
We will fund projects lasting up to five years, although projects typically last three to four years. If your project will last more than three years, you must justify the reason for this; for example, if you need time for data collection or follow-up.
If your project will last less than two years, it must be for proof of principle or pilot work only. We expect proof of principle proposals to support high-risk/high-reward research by critically testing a key hypothesis and/or demonstrating feasibility of an approach that could lead to fundamentally new avenues of research.
Contact one of our programme managers for advice if you would like to apply for a short or long-duration project.
You can request funding for costs such as:
- a contribution to the salary of the principal investigator and co-investigators
- support for other posts such as research and technical
- research consumables
- travel costs
- data preservation, data sharing and dissemination costs
- estates/indirect costs.
We won’t fund:
- research involving randomised trials of clinical treatments
- funding to use as a ‘bridge’ between grants
- costs for PhD studentships
- publication costs.